We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
- Authors
Colhoun, Helen M; Betteridge, D John; Durrington, Paul N; Hitman, Graham A; Neil, H Andrew W; Livingstone, Shona J; Thomason, Margaret J; Mackness, Michael I; Charlton-Menys, Valentine; Fuller, John H; CARDS investigators
- Abstract
Type 2 diabetes is associated with a substantially increased risk of cardiovascular disease, but the role of lipid-lowering therapy with statins for the primary prevention of cardiovascular disease in diabetes is inadequately defined. We aimed to assess the effectiveness of atorvastatin 10 mg daily for primary prevention of major cardiovascular events in patients with type 2 diabetes without high concentrations of LDL-cholesterol.
- Publication
Lancet (London, England), 2004, Vol 364, Issue 9435, p685
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(04)16895-5